Meiwu Technology Co Ltd (WNW) Form 6-K — Aug 26, 2026
Meiwu Technology's wholly owned subsidiary Xiamen Chunshang Health Technology entered an equity transfer agreement on August 20, 2026 to acquire 100% of Xiamen Hemeitong, a functional skincare distributor, for total consideration of RMB 235,200,000, which the 6-K describes as approximately $35,000,000 in cash. Payment is structured in two installments: RMB 70,560,000 first (of which RMB 34,251,000 was already paid to the two sellers on May 10, 2026, leaving RMB 36,309,000) and RMB 164,640,000 due at closing, with commercial registration targeted for completion by August 31, 2026.
Key figures
- Deal Value Usd
- 35000000
- Deal Value Rmb
- RMB 235,200,000 (per Exhibit 10.1 agreement)
- Closing Deadline
- August 31, 2026
- Indemnification Cap
- 5% of consideration (except fraud or willful default)
- Late Payment Penalty
- 0.06% per day of delay
- Target Network Reach
- 1600
- First Installment Rmb
- RMB 70,560,000
- Second Installment Rmb
- RMB 164,640,000
- Presigning Payments Rmb
- RMB 34,251,000 (paid to sellers on May 10, 2026)
- Appraised Equity Value Rmb
- RMB 239,405,140
- Appraised Equity Value Usd
- approximately $35,283,952
- Registration Delay Penalty
- 0.03% of total consideration per day of delay
- Target Registered Capital Rmb
- RMB 100,000 (fully paid)
- Remaining First Installment Rmb
- RMB 36,309,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.